Life-support intervention use after gastrointestinal cancer surgery was strongly associated with adverse short-term outcomes, serving as a marker of postoperative severity.
Observational
Is life-support intervention use associated with adverse short-term outcomes in patients undergoing gastrointestinal cancer surgery?
Life-support intervention use after gastrointestinal cancer surgery is increasing and serves as a strong marker of postoperative severity and adverse short-term outcomes.
After gastrointestinal cancer surgery, intensive care unit use declined while life-support intervention use increased, indicating more selective concentration of higher-acuity postoperative care. Life-support intervention use was strongly associated with adverse short-term outcomes and may serve as a marker of postoperative severity to inform perioperative risk stratification and critical-care resource planning.
Ekenze et al. (Mon,) conducted a observational in Gastrointestinal cancer surgery. Life-support intervention was evaluated on Adverse short-term outcomes. Life-support intervention use after gastrointestinal cancer surgery was strongly associated with adverse short-term outcomes, serving as a marker of postoperative severity.